PCSK9 and familial hypercholesterolemia: 354 Daniels Daniels S S Caprio Caprio S S Chaudhari Chaudhari U U PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study J Clin Lipidol J Clin Lipidol 2020 2020 14 14 3 3 322.e5 322.e5 330.e5 330.e5 32331936 32331936 Daniels S, Caprio S, Chaudhari U et al. PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study.